Equibles does not estimate personal net worth.
Get an email with a short summary when Envista Holdings Corp publishes a filing, an earnings call transcript or a press release.
Get NVST alertsEric Hammes is recorded as CFO at Envista Holdings Corp (NVST). Envista Holdings Corp reported in an 8-K filed July 15, 2024 that Eric Hammes was appointed Senior Vice President and Chief Financial Officer, effective August 8, 2024. The proxy statement of Envista Holdings Corp reports total compensation of $2,645,970 for Eric Hammes in fiscal 2025, including a base salary of $592,308. Disclosed compensation is on record for 2 fiscal years. Eric Hammes has spoken on 8 earnings calls and 3 other investor events across 1 company, most recently for Envista Holdings Corp on November 4, 2026. Envista Holdings Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Envista Holdings Corp includes Paul Keel (Chairman and Board Member), Andrew Chen (CIO), Mark Nance (General Counsel) and 7 others.
“On July 15, 2024, Envista Holdings Corporation (the "Company") announced that it has appointed Eric Hammes as the Senior Vice President and Chief Financial Officer of the Company, with such appointment to be effective as of August 8, 2024.”
“Third quarter sales were $691 million, up $21 million from the prior year. Core sales grew 2.7%. Total growth was 3.2% with neutral FX and a slight tailwind from acquisitions.”
“It's great to get out of the front row seat of the movie theater. So, Robert, let me just say thank you. It's wonderful to see the value that our Dexus business is generating for customers and also about the integration of comprehensive digital solutions across all of InVista.”
“One, at the market level, as Paul talked about in terms of just the macro, our view is that long-term, the dental market and what you see in terms of dental market price inflation, that's largely public data through the services side of dental, right?”
“In the second quarter, we delivered sales of $731 million. Core sales in the quarter increased 5% with FX in recent acquisitions combining to add an additional 200 basis points.”
“In the fourth quarter, we delivered sales of $751 million. Core sales in the quarter increased 10.8%, and FX added nearly 400 basis points. As Paul mentioned, Q4 was another strong quarter for INVISTA with broad-based growth.”
Medical Instruments & Supplies · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Envista Holdings Corp (NVST) | Chief Financial Officer | $592,308 | $2,645,970 |
| 2024 | Envista Holdings Corp (NVST) | Chief Financial Officer, from August 1, 2024 | $575,000 | $3,202,920 |
